Management of cardiovascular diseases in patients with obesity

Nature Reviews Cardiology

Volumn 15, Issue 1, 2018, Pages 45-56

  Lavie, Carl J ^a   Arena, Ross ^b   Alpert, Martin A ^c   Milani, Richard V ^a   Ventura, Hector O ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ATRIAL FIBRILLATION; BARIATRIC SURGERY; BODY COMPOSITION; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CORONARY ARTERY BYPASS SURGERY; GASTRIC BANDING; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HUMAN; HYPERTENSION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; ISCHEMIC HEART DISEASE; MEDICAL RESEARCH; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; ROUX-EN-Y GASTRIC BYPASS; SLEEVE GASTRECTOMY; WEIGHT REDUCTION; BODY WEIGHT LOSS; COMPLICATION; MORBID OBESITY;

CARDIOVASCULAR DISEASES; HUMANS; OBESITY, MORBID; WEIGHT LOSS;

EID: 85037679296     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2017.108     Document Type: Review

References (129)

1. Flegal, K. M., Kruszon-Moran, D., Carroll, M. D., Fryar, C. D. & Ogden, C. L. Trends in obesity among adults in the United States, 2005 to 2014. JAMA 315, 2284-2291 (2016).
2. Lavie, C. J. et al. Obesity and prevalence of cardiovascular diseases and prognosis: The obesity paradox updated. Prog. Cardiovasc. Dis. 58, 537-547 (2016).
3. Lavie, C. J. et al. Update on obesity and obesity paradox in heart failure. Prog. Cardiovasc. Dis. 58, 393-400 (2016).
4. Bastien, M., Poirier, P., Lemieux, I. & Després, J. P. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog. Cardiovasc. Dis. 56, 369-381 (2014).
5. Lavie, C. J. et al. Healthy obese versus unhealthy lean: The obesity paradox. Nat. Rev. Endocrinol. 11, 55-62 (2015).
6. Wilson, P. W. F. et al. Overweight and obesity as determinants of cardiovascular risk: The Framingham Experience. Arch. Intern. Med. 162, 1867-1872 (2002).
7. Gelber, R. P. et al. A prospective study of body mass index and the risk of developing hypertension in men. Am. J. Hypertens. 20, 370-377 (2007).
8. Lavie, C. J., De Schutter, A. & Milani, R. V. in Chronic Coronary Artery Disease: A Companion to Braunwald's Heart Disease (eds de Lemos, J. & Omland, T.) 270-279 (2017).
9. Mokdad, A. H. et al. Diabetes trends in the US: 1990-1998. Diabetes Care. 23, 1278-1283 (2000).
10. Lavie, C. J., Milani, R. V., O'Keefe, J. H. Dyslipidemia intervention in metabolic syndrome: emphasis on improving lipids and clinical event reduction. Am. J. Med. Sci. 341, 388-393 (2011).
11. Miller, M. T., Lavie, C. J. & White, C. J. Impact of obesity on the pathogenesis and prognosis of coronary heart disease. J. Cardiometab Syndr. 3, 162-167 (2008).
12. Alexander, C. M. et al. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52, 1210-1214 (2003).
13. Cawthorn, W. P., Scheller, E. L. & MacDougald, O. A. Adipose tissue stem cells meet preadipocyte commitment: going back to the future. J. Lipid Res. 53, 227-246 (2012).
14. Lavie, C. J., Oktay, A. A. & Pandey, A. Pericardial fat and CVD: is all fat created equally? JACC Cardiovasc. Imaging http://dx.doi.org/10.1016/j.jcmg.2016.11.018 (2017).
15. Alpert, M. A., Lavie, C. J., Agrawal, H., Aggarwal, K. & Kumar, S. A. Obesity and heart failure. Epidemiology, pathophysiology, clinical manifestations, and management. Transl. Res. 164, 345-356 (2014).
16. Alpert, M. A., Omran, J., Mehra, A. & Ardhanari, S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog. Cardiovasc. Dis. 56, 391-400 (2014).
17. Lavie, C. J. et al. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 1, 93-1021 (2013).
18. Alexander, J. K. & Alpert, M. A. (eds) in The Heart and Lung in Obesity. 45-56 (Wiley-Blackwell, 1998).
19. Poirier, P. et al. Obesity and cardiovascular disease: pathophysiology evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113, 898-918 (2006).
20. Kasper, E. K., Hruban, R. H. & Baughman, K. L. Cardiomyopathy of obesity: A clinical pathological evaluation of 43 obese patients with heart failure. Am. J. Cardiol. 70, 921-924 (1992).
21. Bella, N. J. et al. Relations of left ventricular mass to fat-free and adipose body mass: The Strong Heart Study. Circulation 98, 2538-2544 (1998).
22. McGavock, J. M., Victor, R., Unger, R. H. & Szczepaniak, L. S. Adiposity of the heart revisited. Ann. Intern. Med. 144, 515-524 (2006).
23. Woodwiss, A. J. et al. Obesity promotes left ventricular concentric rather than eccentric geometric remodeling and hypertrophy independent of blood pressure. Am. J. Hypertension. 21, 1149-1153 (2008).
24. Aurigemma, G. P., de Simone, G. & Fitzgibbons, T. P. Cardiac remodeling in obesity. Circ. Cardiovasc. Imag. 6, 442-452 (2013).
25. Peterson, L. R. et al. Alterations in left ventricular structure and function in young health obese women. J. Am. Coll. Cardiol. 43, 1399-1404 (2004).
26. Okpura, I. C. et al. Left ventricular geometric patterns in obese Nigerian adults: An echocardiographic study. Internet J. Intern. Med. 9, 1-7 (2010).
27. De Simone, G. et al. Relative fat-free mass deficiency and left ventricular adaptation to obesity: The Strong Heart Study. Int. J. Cardiol. 168, 729-733 (2013).
28. Pascual, M. et al. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart 89, 1152-1156 (2003).
29. Chakko, S. et al. Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity. Am. J. Cardiol. 68, 95-98 (1991).
30. Kossaify, A. & Nicolais, N. Impact of overweight and obesity on left ventricular diastolic function and value of tissue Doppler echocardiography. Clin. Med. Insights Cardiol. 7, 43-50 (2013).
31. Barbosa, M. M. et al. Strain imaging and morbid obesity: insight into subclinical ventricular dysfunction. Clin. Cardiol. 34, 288-293 (2011).
32. Patel, D. A. et al. Association of left ventricular geometry with left atrial enlargement in patients with preserved ejection fraction. Congest. Heart Fail. 18, 4-8 (2012).
33. Chahai, H. et al. Obesity and right ventricular structure and function: The MESA-Right Ventricular Study. Chest 141, 388-395 (2012).
34. Abdullah, S. et al. The impact of obesity on right ventricular function in young adults. Am. J. Cardiol. 101, 160-168 (2013).
35. Iacobellis, G. Relation of epicardial fat thickness to right ventricular cavity size in obese subjects. Am. J. Cardiol. 104, 1601-1602 (2009).
36. Arena, A. et al. The combination of obesity and hypertension: A highly unfavorable phenotype requiring attention. Curr. Opin. Cardiol. 31, 394-401 (2016).
37. Lavie, C. J. et al. Impact of echocardiographic left ventricular geometry on clinical prognosis. Prog. Cardiovasc. Dis. 57, 3-9 (2014).
38. Oktay, A. A. et al. Current perspectives on left ventricular geometry in systemic hypertension. Prog. Cardiovasc. Dis. 59, 235-246 (2016).
39. Uretsky, S. et al. Obesity paradox in patients with hypertension and coronary artery disease. Am. J. Med. 120, 863-870 (2007).
40. Lavie, C. J. et al. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am. J. Cardiol. 100, 1460-1464 (2007).
41. Patel, D. A. et al. Effects of left ventricular geometry and obesity on mortality in women with normal ejection fraction. Am. J. CardioI. 113, 877-880 (2014).
42. Arena, R. et al. Assessment of functional capacity in clinical and research settings: A scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. Circulation 116, 329-343 (2007).
43. Lavie, C. J. et al. Exercise and the cardiovascular system: clinical science and outcome. Circ. Res. 117, 207-219 (2015).
44. Balady, G. J. et al. Clinician's guide to cardiopulmonary exercise testing in adults: A scientific statement from the American Heart Association. Circulation 122, 191-225 (2010).
45. Fletcher, G. F. et al. Exercise standards for testing and training: A scientific statement from the American Heart Association. Circulation 128, 873-934 (2013).
46. Arena, R., Myers, J. & Guazzi, M. The future of aerobic exercise testing in clinical practice: is it the ultimate vital sign? Future Cardiol. 6, 325-342 (2010).
47. Guazzi, M. et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 126, 2261-2274 (2012).
48. Myers, J. et al. Recommendations for clinical exercise laboratories: A scientific statement from the American Heart Association. Circulation 119, 3144-3161 (2009).
49. Waldburger, R. et al. Comprehensive assessment of physical functioning in bariatric surgery candidates compared with subjects without obesity. Surg. Obes. Relat. Dis. 13, 642-650 (2016).
50. Lerner, Z. F., Board, W. J. & Browning, R. C. Effects of obesity on lower extremity muscle function during walking at two speeds. Gait Posture 39, 978-984 (2014).
51. Lavie, C. J., McAuley, P. A., Church, T. S., Milani, R. V. & Blair, S. N. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J. Am. Coll. Cardiol. 63, 1345-1354 (2014).
52. Sui, X. et al. Cardiorespiratory fitness and adiposity as mortality predictors in older adults. JAMA 298, 2507-2516 (2007).
53. Barry, V. W. et al. Fitness versus fatness on all-cause mortality: A meta-Analysis. Prog. Cardiovasc. Dis. 56, 382-390 (2014).
54. Lavie, C. J. et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin. Proc. 88, 251-258 (2013).
55. McAuley, P. A. & Beavers, K. M. Contribution of cardiorespiratory fitness to the obesity paradox. Prog. Cardiovasc. Dis. 56, 434-440 (2014).
56. Chase, P. et al. Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure. Am. J. Cardiol. 101, 348-352 (2008).
57. McCullough, P. A. et al. Cardiorespiratory fitness and short-Term complications after bariatric surgery. Chest 130, 517-525 (2006).
58. Hennis, P. J. et al. Cardiopulmonary exercise testing predicts postoperative outcome in patients undergoing gastric bypass surgery. Br. J. Anaesth. 109, 566-571 (2012).
59. Wilms, B., Ernst, B., Thurnheer, M., Weisser, B. & Schultes, B. Differential changes in exercise performance after massive weight loss induced by bariatric surgery. Obes. Surg. 23, 365-371 (2013).
60. de Souza, S. A., Faintuch J. & Sant'anna A. F. Effect of weight loss on aerobic capacity in patients with severe obesity before and after bariatric surgery. Obes. Surg. 20, 871-875 (2010).
61. Di Thommazo-Luporini, L. et al. Are cardiovascular and metabolic responses to field walking tests interchangeable and obesity-dependent? Disabil. Rehabil. 38, 1820-1829 (2016).
62. Di Thommazo-Luporini, L. et al. The six-minute step test as a predictor of cardiorespiratory fitness in obese women. Eur. J. Phys. Rehabil. Med. 51, 793-802 (2015).
63. Carvalho, L. P. et al. Prediction of cardiorespiratory fitness by the six-minute step test and its association with muscle strength and power in sedentary obese and lean young women: A cross-sectional study. PLoS ONE 10, e0145960 (2015).
64. Silveira, M. G. et al. Assessment of myocardial ischemia in obese individuals undergoing physical stress echocardiography (PSE). Arq. Bras. Cardiol. 104, 394-400 (2015).
65. Shah, B. N. et al. The clinical impact of contemporary stress echocardiography in morbid obesity for the assessment of coronary artery disease. Heart 102, 370-375 (2016).
66. Supariwala, A. et al. Feasibility and prognostic value of stress echocardiography in obese, morbidly obese, and super obese patients referred for bariatric surgery. Echocardiography 31, 879-885 (2014).
67. Minutello, R. M. et al. Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry). Am. J. Cardiol. 93, 1229-1232 (2004).
68. Lavie, C. J., Milani, R. V. & Ventura, H. O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol. 53, 1925-1932 (2009).
69. Sharma, A. et al. Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-Analysis. Mayo Clin. Proc. 89, 1080-1100 (2014).
70. Powell, B. D. et al. Association of body mass index with outcome after percutaneous coronary intervention. Am. J. Cardiol. 91, 472-476 (2003).
71. Habib, R. H. et al. Effects of obesity and small body size on operative and long-Term outcomes of coronary artery bypass surgery: A propensity-matched analysis. Ann. Thorac Surg. 79, 1976-1986 (2005).
72. Pan, W. et al. Obesity in diabetic patients undergoing coronary artery bypass graft surgery is associated with increased postoperative morbidity. Anesthesiology 104, 441-447 (2006).
73. Romero-Corral, A. et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies. Lancet 368, 666-678 (2006).
74. Wang, Z. J. et al. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: A systematic review and meta-Analysis. Heart 101, 1631-1638 (2015).
75. Flegal, K. M., Kit, B. K., Orpana, H. & Graubard, B. L. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-Analysis. JAMA 309, 71-82 (2013).
76. De Schutter, A., Lavie, C. J., Patel, D. A., Artham, S. M. & Milani, R. V. Relation of body fat categories by Gallagher classification and by continuous variables to mortality in patients with coronary heart disease. Am. J. Cardiol. 111, 657-660 (2013).
77. De Schutter, A., Lavie, C. J., Arce, K., Menedez, S. G. & Milani, R. V. Correlation and discrepancies between obesity by body mass index and body fat in patients with coronary heart disease. J. Cardiopulm Rehabil. Prev. 33, 77-83 (2013).
78. De Schutter, A., Lavie, C. J., Patel, D. A. & Milani, R. V. Obesity paradox and the heart: which indicator of obesity best describes this complex relationship? Curr. Opin. Clin. Nutr. Metab. Care. 16, 517-524 (2013).
79. Ortega, F. B., Sui, X., Lavie, C. J. & Blair, S. N. Body mass index, the most widely used but also widely criticized index: would a criterion standard measure of total body fat be a better predictor of cardiovascular disease mortality. Mayo Clin. Proc. 91, 443-455 (2016).
80. Ortega, F. B., Lavie, C. J. & Blair, S. N. Obesity and cardiovascular disease. Circ. Res. 118, 1752-1770 (2016).
81. De Schutter, A., Lavie, C. J. & Milani, R. V. The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease: The obesity paradox. Prog. Cardiovasc. Dis. 56, 401-408 (2014).
82. Lavie, C. J., De Schutter, A., Patel, D., Artham, S. M. & Milani, R. V. Body composition and coronary heart disease mortality: An obesity or a lean paradox? Mayo Clin. Proc. 86, 857-864 (2011).
83. Lavie, C. J., Milani, R. V., Artham, S. M., Patel, D. A. & Ventura, H. O. The obesity paradox, weight loss, and coronary disease. Am. J. Med. 122, 1106-1114 (2009).
84. Lavie, C. J. et al. Body composition and survival in stable coronary heart disease: impact of lean mass index and body fat in the "obesity paradox." J. Am. Coll. Cardiol. 60, 1374-1380 (2012).
85. McAuley, P. A. et al. The obesity paradox, cardiorespiratory fitness, and coronary heart disease. Mayo Clin. Proc. 87, 443-451 (2012).
86. Azimi, A. et al. Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease. Heart 99, 655-660 (2013).
87. Lavie, C. J., De Schutter, A. & Milani, R. V. Is there an obesity, overweight or lean paradox in coronary heart disease? Getting to the 'fat' of the matter. Heart 99, 596-598 (2013).
88. Kenchaiah, S. et al. Obesity and the risk of heart failure. N. Engl. J. Med. 347, 305-313 (2002).
89. Mehra, M. R. et al. Obesity and suppressed B-Type natriuretic peptide levels in heart failure. J. Am. Coll. Cardiol. 43, 1590-1595 (2004).
90. Alpert, M. A., Lavie, C. J., Agrawal, H., Kumar, A. & Kumar, S. A. Cardiac effects of obesity: pathophysiologic, clinical, and prognostic consequences-A review. J. Cardiopulm. Rehabil. Prev. 36, 1-11 (2016).
91. Sharma, A. et al. Meta-Analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am. J. Cardiol. 115, 1428-1434 (2015).
92. Shah, R.et al. Body mass index and mortality in acutely decompensated heart failure across the world: A global obesity paradox. J. Am. Coll. Cardiol. 63, 778-785 (2014).
93. Lavie, C. J. & Ventura, H. O. The obesity paradox in heart failure: is it all about fitness, fat, or sex? JACC Heart Fail. 3, 927-930 (2015).
94. Vest, A. R., Wu, Y., Hachamovitch, R., Young, J. B. & Cho, L. S. The heart failure overweight/obesity survival paradox: The missing sex link. JACC Heart Fail. 3, 917-926 (2015).
95. Morin, D. P. The state of the art: Atrial fibrillation epidemiology, prevention, and treatment. Mayo Clin. Proc. 91, 1778-1810 (2016).
96. Menezes, A. R. et al. Lifestyle modification in the prevention and treatment of atrial fibrillation. Prog. Cardiovasc. Dis. 58, 117-125 (2015).
97. Sheikh, A. et al. Trends in hospitalization in atrial fibrillation: epidemiology, cost, and implications for the future. Prog. Cardiovasc. Dis. 58, 105-116 (2015).
98. Morin, D. P. & Estes, N. A. Advances in the prevention and treatment of atrial fibrillation. Prog. Cardiovasc. Dis. 58, 103-104 (2015).
99. Wanahita, N. et al. Atrial fibrillation and obesity: results of a meta-Analysis. Am. Heart J. 155, 310-315 (2008).
100. Wang, T. J. et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 292, 2471-2477 (2004).
101. Tsang, T. S. et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: A longitudinal cohort study of 21 years. Eur. Heart J. 29, 2227-2233 (2008).
102. Badheka, A. O. et al. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox. Am. J. Med. 123, 646-651 (2010).
103. Pathak, R. K. et al. Impact of CARDIOrespiratory FITness on arrhythmia recurrence in obese individuals with atrial fibrillation: The CARDIO-FIT study. J. Am. Coll. Cardiol. 66, 985-996 (2015).
104. Allison, D. B. et al. Weight loss increases and fat loss decreases all-cause mortality rates: results from two independent cohort studies. Int. J. Obes. Relat. Metab. Disord. 23, 603-611 (1999).
105. Pathak, R. K. et al. Long-Term effect of goal directed weight management in an atrial fibrillation cohort: A long-Term follow-up study (LEGACY Study). J. Am. Coll. Cardiol. 65, 2159-2169 (2015).
106. Sengenes, C. et al. Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women. Int. J. Obes. Relat. Metab. Disord. 26, 24-32 (2002).
107. Kistorp, C. et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112, 1756-1762 (2005).
108. Qi, Y. et al. Adiponectin acts in the brain to decrease body weight. Nat. Med. 10, 524-529 (2004).
109. Swift, D. L., Johannsen, N. M., Lavie, C. J., Earnest, C. P. & Church, T. S. The role of exercise and physical activity in weight loss and maintenance. Prog. Cardiovasc. Dis. 56, 441-447 (2014).
110. Ades, P. A. & Savage, P. D. Potential benefits of weight loss in coronary heart disease. Prog. Cardiovasc. Dis. 56, 448-456 (2014).
111. Look AHEAD Research Group et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N. Engl. J. Med. 369, 145-154 (2013).
112. Alpert, M. A. et al. Factors influencing left ventricular systolic function in non-hypertensive morbidly obese patients and effect of weight loss induced by gastroplasty. Am. J. Cardiol. 75, 773-777 (1993).
113. Alexander, J. K. & Petersen, K. L. Cardiovascular effects of weight reduction. Circulation 45, 310-318 (1972).
114. Alpert, M. A. et al. Cardiac morphology and left ventricular function in morbidly obese patients with and without congestive heart failure. Am. J. Cardiol. 80, 736-740 (1997).
115. Backman, L. et al. Reversibility of cardiopulmonary changes in extreme obesity. Act Med. Scand. 205, 367-373 (1979).
116. Ashrafian, H. et al. Effects of bariatric surgery on cardiovascular function. Circulation 118, 2091-2102 (2008).
117. McCloskey, C. D. et al. Bariatric surgery improves cardiac function in morbidly obese patients with serve cardiomyopathy. Surg. Obes. Relat. Dis. 3, 503-507 (2007).
118. Rider, O. J. et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J. Am. Coll. Cardiol. 54, 718-726 (2009).
119. Grapsa, J. et al. The effect of bariatric surgery on echocardiographic indices: A review of the literature. Eur. J. Clin. Invest. 42, 1224-1230 (2013).
120. Luaces, M. et al. Anatomical and functional alterations of the heart in morbid obesity. Changes after bariatric surgery. Rev. Esp. Cardiol. (Engl. Ed). 65, 14-21 (2012).
121. Alpert, M. A. et al. Effect of weight loss on left ventricular diastolic filling in morbid obesity. Am. J. Cardiol. 80, 736-740 (1997).
122. Vest, A. R. et al. Clinical and echocardiographic outcomes after bariatric surgery in obese patients with left ventricular systolic dysfunction. Circ. Heart Fail. 9, e002260 (2016).
123. Sokmen, A. et al. The impact of isolated obesity on right ventricular function in young adults. Arq. Bras. Cardiol. 101, 160-168 (2013).
124. Writing Committee Members et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128, e240-e327 (2013).
125. Pack, Q. R. et al. The prognostic importance of weight loss in coronary artery disease: A systematic review and meta-Analysis. Mayo Clin. Proc. 89, 1368-1377 (2014).
126. Kushner, R. F. Weight loss strategies for treatment of obesity. Prog. Cardiovasc. Dis. 5, 465-472 (2014).
127. Vest, A. R. et al. Surgical management of obesity and the relationship to cardiovascular disease. Circulation 127, 945-959 (2013).
128. Buchwald, H. et al. Bariatric surgery: A systematic review and meta-Analysis. JAMA 292, 1724-1737 (2004).
129. Sjostrom, L. et al. Bariatric surgery and long-Term cardiovascular events. JAMA 307, 56-65 (2012).